Arcutis Biotherapeutics Inc (ARQT)
EBITDA Margin
9.36%
TTM · Period ending:
ARQT EBITDA Margin
Latest reported9.36%period ending
Latest reported9.36%period ending
ARQT TTM EBITDA Margin (-41559.31% → 9.36%)
TTM ebitda margin
High-resolution chart · PNG
ARQT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 9.3601% | |
| 3.4473% | |
| 0.514% | |
| -7.5338% | |
| -26.071% | |
| -47.7246% | |
| -56.0287% | |
| -118.0725% | |
| -124.153% | |
| -171.4232% | |
| -382.2753% | |
| -478.1795% | |
| -2,601.3211% | |
| -4,719.8237% | |
| -7,999.783% | |
| -41,559.3103% |